These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 502312

  • 1. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
    Fisanovich TI, Tolstova LG.
    Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A, Borri P, Parravicini R.
    Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
    [No Abstract] [Full Text] [Related]

  • 3. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
    Hunyi L.
    Ther Hung; 1976 Nov; 24(2):67-71. PubMed ID: 982342
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K, Oliva I, Linhart J, Prerovský I, Modr Z.
    Cas Lek Cesk; 1976 Aug 27; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
    Fényes G, Gótzy G, Fehrentheil L.
    Ther Hung; 1975 Aug 27; 23(2):64-66. PubMed ID: 1188705
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
    Makinskiĭ AI, Safarov RN, Fondaminskaia LD, Semenova AS, Fedotova NN.
    Probl Tuberk; 1979 Jan 27; (1):26-30. PubMed ID: 368764
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The use of regional artificial circulation in the treatment of obliterating thrombosis of the lower limbs].
    Dutkevich IG, Farshatov MN, Glebov IuI, Dekster BG.
    Vestn Khir Im I I Grek; 1966 Jun 27; 96(6):122-6. PubMed ID: 6000568
    [No Abstract] [Full Text] [Related]

  • 12. [Intra-arterial infusion in the treatment of severe forms of occlusive vascular diseases of the lower limbs].
    Lytkin MI, Nazarov GD, Barinov VS.
    Vestn Khir Im I I Grek; 1981 Jan 27; 126(1):78-82. PubMed ID: 7222426
    [Abstract] [Full Text] [Related]

  • 13. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P, Abbadessa V, Pecorella M, Cajozzo A.
    Boll Soc Ital Cardiol; 1977 Jan 27; 22(7):1036-41. PubMed ID: 618239
    [No Abstract] [Full Text] [Related]

  • 14. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    J Pharm Sci; 1975 Jan 27; 64(1):261-9. PubMed ID: 1094102
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN, Aleksandrova LM, Kliachko VR, Mazovetskiĭ AG.
    Ter Arkh; 1974 Jan 27; 46(1):107-10. PubMed ID: 4453966
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of patients with obliterating vascular diseases of the extremities].
    Vakhidov VV, Khachiev LG.
    Khirurgiia (Mosk); 1968 Dec 27; 44(12):82-7. PubMed ID: 5711636
    [No Abstract] [Full Text] [Related]

  • 18. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J, Lysakowska-Sernicka K, Gajewska A, Bilińska-Nigot B, Ostrowski K, Semenicki K.
    Neurol Neurochir Pol; 1978 Dec 27; 12(4):387-96. PubMed ID: 714218
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.